The DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
At Issue: Schizophrenia and Rheumatoid Arthritis: The Negative Association Revisited
Abstract
A strong negative association between schizophrenia and rheumatoid arthritis (RA), implying low comorbidity, has been found in 12 of 14 previous studies, which we review. To this literature we add two recently acquired data sets encompassing 28,953 schizophrenia patients, only 31 of whom had comorbid RA. Integrating our new data into those of the previous nine studies, which stratified their populations according to psychiatric diagnosis, we obtain a median frequency of RA in schizophrenia populations of 0.09 percent and a mean frequency of 0.66 percent, well below the expected range of 1 percent. These data robustly support prior studies. We also present a meta-analysis evaluating the association between the two diseases by integrating information derived from nine data sets, each furnishing an estimate of the relative risk of RA in schizophrenia patients versus that in other psychiatric patients. We find that the estimated rate of RA among schizophrenia patients is only 29 percent of the corresponding rate in other psychiatric patients. Further, the relative risk of RA in schizophrenia patients versus that in the general population is even less than 29 percent and could be as low as one-third of this value. We present a new hypothesis involving the platelet activating factor system in an effort to account for this negative association and review the suggestions of other investigators toward this end. Finally, we consider the glutamatergic system dysfunction hypothesis of schizophrenia and suggest a possible common pharmacological approach that may ameliorate some of the symptomatology of both schizophrenia and RA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A consistent finding is the negative relationship between schizophrenia and autoimmune diseases.”
From Excess early mortality in schizophrenia. (2014) · cites this paper as Oken & Schulzer 1999
In the citing paper
“Rheumatoid arthritis in particular has been shown to have a negative correlation with schizophrenia (Eaton et al. 1992(Eaton et al. , 2006;;Oken & Schulzer 1999).”
From Excess early mortality in schizophrenia. (2014) · cites this paper as Oken & Schulzer 1999
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
The Proceedings of the National Academy of Sciences
Richards, J. W. (1915) · Science · doi:10.1126/science.42.1074.161 · Cited by 13,941
The file drawer problem and tolerance for null results.
Rosenthal, R. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.3.638 · Cited by 9,068
Statistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 9,034
Biochemical and Biophysical Research Communications
Rc, A. N., On Filamentous Bacteriophage, M., Hoffmann, S., & Willbold, D. (1960) · Nature · doi:10.1038/186124d0 · Cited by 6,690
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,840
Statistical Methods for Rates and Proportions, 2nd ed
GROVE, W. A. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.12.1644-a · Cited by 3,756
The Handbook of Research Synthesis.
Howel, D., Cooper, H., & Hedges, L. V. (1995) · Biometrics · doi:10.2307/2533295 · Cited by 3,657
The Handbook of Research Synthesis.
Light, R. J., Cooper, H., & Hedges, L. V. (1994) · Journal of the American Statistical Association · doi:10.2307/2291021 · Cited by 1,880
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Progress in Clinical and Biological Research
Smyth, J. F. (1979) · Journal of Clinical Pathology · doi:10.1136/jcp.32.7.742-d · Cited by 1,558
Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation
Grilli, M., Pizzi, M., Memo, M., & Spano, P. (1996) · Science · doi:10.1126/science.274.5291.1383 · Cited by 751
Cost of Relapse in Schizophrenia
Weiden, P. J., & Olfson, M. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.3.419 · Cited by 665
Anti-inflammatory properties of a platelet-activating factor acetylhydrolase
Tjoelker, L. W., Wilder, C., Eberhardt, C., Stafforinit, D. M., Dietsch, G., Schimpf, B. A., Hooper, S., Trong, H. L., Cousens, L. S., Zimmerman, G. A., et al. (1995) · Nature · doi:10.1038/374549a0 · Cited by 525
Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor
Hattori, M., Adachi, H., Tsujimoto, M., Arai, H., & Inoue, K. (1994) · Nature · doi:10.1038/370216a0 · Cited by 465
Horrobin, D. F. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00151-5 · Cited by 456
Anti-inflammatory drugs and Alzheimer disease
McGeer, P. L., McGeer, E. G., Rogers, J., & Sibley, J. T. (1990) · The Lancet · doi:10.1016/0140-6736(90)91101-f · Cited by 437
Increased biosynthesis of platelet-activating factor in activated human eosinophils.
Lee, T., Lenihan, D. J., Malone, B., Roddy, L. L., & Wasserman, S. I. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91044-6 · Cited by 409
Akbarian, S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050061010 · Cited by 397
Schizophrenia: A Subcortical Neurotransmitter Imbalance Syndrome?
Carlsson, M. L., & Carlsson, A. C. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.425 · Cited by 341
Schizophrenia-Like Psychosis and Epilepsy: The Status of the Association
Sachdev, P. S. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.3.325 · Cited by 331
Prostaglandins, Leukotrienes and Essential Fatty Acids
Kaur, G., Sinclair, A. J., Cameron‐Smith, D., Barr, D. P., Molero, J. C., & Konstantopoulos, N. (2009) · Cited by 321
Sapir, T., Elbaum, M., & Reiner, O. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.6977 · Cited by 304
THE JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Weil, A. (1962) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196201000-00001 · Cited by 273
A “Glutamatergic Hypothesis” of Schizophrenia
Deutsch, S. I., Mastropaolo, J. P., Schwartz, B. L., Rosse, R. B., & Morihisa, J. M. (1989) · Clinical Neuropharmacology · doi:10.1097/00002826-198902000-00001 · Cited by 268
Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients
Zarrabi, M. H., ZUCKER, S., MILLER, F., DERMAN, R. M., ROMANO, G. S., HARTNETT, J. A., & VARMA, A. O. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-2-194 · Cited by 230
Bartha, R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220085012 · Cited by 230
Modes of action of aspirin-like drugs.
Abramson, S. B., Korchak, H. M., Ludewig, R., Edelson, H. S., HAINES, K. A., Levin, R. I., Herman, R., Rider, L. G., Kimmel, S. C., & Weissmann, G. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7227 · Cited by 219
EPIDEMIOLOGY OF SCHIZOPHRENIA1
EATON, W. W. (1985) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036278 · Cited by 194
Increased serum phospholipase A2 activity in schizophrenia: a replication study.
Wf, G., Cv, H., Tj, N., Thuren, T. Y., & Pk, K. (1990) · PubMed · Cited by 186
Schizophrenia and rheumatoid arthritis: a review
Eaton, W. W., Hayward, C., & Ram, R. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90001-l · Cited by 172
Peet, M., Laugharne, J. D. E., Mellor, J. E., & Ramchand, C. N. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90148-9 · Cited by 170
Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer
Ho, Y. S. J., Swenson, L. L., Derewenda, U., Serre, L., Wei, Y., Dauter, Z., Hattori, M., Adachi, T., Aoki, J., Arai, H., et al. (1997) · Nature · doi:10.1038/385089a0 · Cited by 169
Rheumatic Disease Clinics of North America
(2021) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00010-7 · Cited by 166
Australian and New Zealand Journal of Medicine
(2010) · Australian and New Zealand Journal of Medicine · doi:10.1111/(issn)1445-5994a · Cited by 146
Horrobin, D. F., Glen, A. I. M., & Hudson, C. J. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90246-5 · Cited by 107
Does dysplasia cause anatomical dysconnectivity in schizophrenia?
Bullmore, E. T., Woodruff, P. W. R., Wright, I. C., Rabe‐Hesketh, S., Howard, R. J., Shuriquie, N., & Murray, R. M. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00141-2 · Cited by 106
Autoimmune diseases in the pedigrees of schizophrenic and control subjects
Wright, P., Sham, P. C., Gilvarry, C. M., Jones, P. B., Cannon, M. D., Sharma, T., & Murray, R. M. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(96)82950-1 · Cited by 105
Eastwood, S. L., Burnet, P. W. J., & Harrison, P. J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00195-7 · Cited by 101
Glutamate: a new target in schizophrenia?
Wachtel, H., & Turski, L. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90243-2 · Cited by 99
Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia
Wright, P., Donaldson, P. T., Underhill, J. A., Choudhuri, K., Doherty, D. G., & Murray, R. M. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1530 · Cited by 95
Glutamate in schizophrenia: clinical and research implications
GOFF, D. C., & Wine, L. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00079-0 · Cited by 93
Excitatory Amino Acid Receptors in Schizophrenia
Ułas, J., & Cotman, C. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.1.105 · Cited by 91
Albrecht, U., Abu‐Issa, R., Rätz, B., Hattori, M., Aoki, J., Arai, H., Inoue, K., & Gregor Eichele, C. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0330 · Cited by 80
Puri, B. K., & Richardson, A. J. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.188 · Cited by 73
Bazan, N. G. (1995) · Nature · doi:10.1038/374501a0 · Cited by 72
Negative Association Between Schizophrenia and Rheumatoid Arthritis
Vinogradov, S., Gottesman, I. I., Moises, H. W., & Nicol, S. E. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.4.669 · Cited by 72
Omega‐3 fatty acid supplementation in schizophrenic patients
Mellor, J. E., Laugharne, J. D. E., & Peet, M. (1996) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199601)11:1 · Cited by 67
Sandy, J. D., Lowther, D. A., & Brown, H. L. G. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230406 · Cited by 57
Blank, M. L., Lee, Y. J., Cress, E. A., & Snyder, F. F. C. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60615-5 · Cited by 57
Absence of Rheumatoid Arthritis in Schizophrenia*
Mellsop, G. W., Koadlow, L., Syme, J., & Whittingham, S. (1974) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1974.tb03183.x · Cited by 54
Phospholipase A2 and the hypofrontality hypothesis of schizophrenia
Gattaz, W. F., & Brunner, J. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90154-4 · Cited by 52
The Psychogenic Problem (Endocrinal and Metabolic) in Chronic Arthritis
NISSEN, H. A., & Spencer, K. A. (1936) · New England Journal of Medicine · doi:10.1056/nejm193603192141205 · Cited by 51
Clark, G., Mizuguchi, M., Antalffy, B. A., BARNES, J., & Armstrong, D. L. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199709000-00009 · Cited by 51
HLA antigens and schizophrenia: A pool of two studies
Gattaz, W. F., Beckmann, H., & Mendlewicz, J. (1981) · Psychiatry Research · doi:10.1016/0165-1781(81)90042-1 · Cited by 49
Schizophrenia and rheumatic disease
Österberg, E. (1978) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1978.tb00240.x · Cited by 48
THE COINCIDENCE OF RHEUMATOID ARTHRITIS AND SCHIZOPHRENIA
Pilkington, T. L. (1956) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195612000-00007 · Cited by 45
Villani, A., Cirino, N. M., Baldi, E., KESTER, M. A., McFadden, E. R., & Panuska, J. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67619-2 · Cited by 45
Baldwin, J. A. (1980) · Springer eBooks · doi:10.1007/978-94-009-8706-7_21 · Cited by 44
THE PAUCITY OF ARTHRITIS AMONG PSYCHOTIC CASES
Gregg, D. (1939) · American Journal of Psychiatry · doi:10.1176/ajp.95.4.853 · Cited by 42
Bell, R., Collier, D. A., Rice, S. Q. J., Roberts, G. W., Macphee, C. H., Kerwin, R. W., Price, J., & Gloger, I. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7741 · Cited by 37
Rheumatoid arthritis in criminal and mentally III populations
Rothermich, N. O., & Philips, V. K. (1963) · Arthritis & Rheumatism · doi:10.1002/art.1780060507 · Cited by 36
Jones‐Brando, L. V., Buthod, J. L., Holland, L. E., Yolken, R. H., & Torrey, E. F. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00007-8 · Cited by 31
Allebeck, P., Rodvall, Y., & Wistedt, B. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb02556.x · Cited by 30
Effects of psychoactive drugs on in vitro lymphocyte activation.
Rm, F., Schmidtke, J. R., & Rl, S. (1978) · PubMed · Cited by 30
Common Medical Disorders Rarely Found in Psychotic Patients
Ehrentheil, O. F. (1957) · A M A Archives of Neurology & Psychiatry · doi:10.1001/archneurpsyc.1957.02330320076010 · Cited by 28
The Association of Certain Vegetative Disturbances with Various Psychoses
Ross, W. D., HAY, J., & McDOWALL, M. F. (1950) · Psychosomatic Medicine · doi:10.1097/00006842-195005000-00005 · Cited by 21
Nakagawa, Y., Sugai, M., Karasawa, K., Tokumura, A., Tsukatani, H., Setaka, M., & Nojima, S. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90241-m · Cited by 19
Mohamed, S. N., Merskey, H., Kazarian, S., & Disney, T. F. (1982) · The Canadian Journal of Psychiatry · doi:10.1177/070674378202700505 · Cited by 18
Snyder, F. F. C. (1988) · PubMed · Cited by 16
Blank, M. L., Smith, Z. L., Cress, E. A., & Snyder, F. F. C. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90001-e · Cited by 16
Effects of chlorpromazine on antibody production in vitro.
Cl, L., Jt, U., Bg, S., & Al, G. (1978) · PubMed · Cited by 11
Immunoglobulin levels in psychotic patients
Gowdy, J. M. (1980) · Psychosomatics · doi:10.1016/s0033-3182(80)73619-8 · Cited by 10
Schizophrenia and psychosomatic illness
Ramsay, R. A., Ananth, J., Engelsmann, F. F., Krakowski, A. J., Wittkower, E. D., & GHADIRIAN, A. M. (1982) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(82)90060-5 · Cited by 10
Pettipher, E. R., & Blake, S. M. (1995) · Elsevier eBooks · doi:10.1016/b978-012340440-4/50056-8 · Cited by 9
ARTHROPATHIES AND SCHIZOPHRENIA
Gattaz, W., Kasper, S. F., Ewald, R. W., & Beckmann, H. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91861-9 · Cited by 8
Approaches to Novel Anti-arthritic Drugs by Modulation of the Arachidonic Acid Cascade
McMillan, R. M., Foster, S. J., & Shaw, J. S. (1995) · Elsevier eBooks · doi:10.1016/b978-012340440-4/50046-5 · Cited by 7
The synergism between platelet-activating factor and interleukin-1 on cartilage breakdown.
Howat, D. W., Desa, F. M., Chander, C. L., Moore, A., & Willoughby, D. A. (1990) · PubMed · Cited by 7
Nowakowski, R. S. (1991) · Springer eBooks · doi:10.1007/978-1-4615-3378-8_2 · Cited by 4
Prevalence of Psychosomatic Disorders in Schizophrenic Patients in Poland
Krakowski, A. J., Rydzyński, Z., Jarosz, M., & Engelsmann, F. F. (1983) · Springer eBooks · doi:10.1007/978-1-4684-4496-4_8 · Cited by 3
A Neurodevelopmental Approach to Schizophrenia Research
Lafosse, J. M., & Mednick, S. A. (1991) · Springer eBooks · doi:10.1007/978-1-4615-3378-8_11 · Cited by 3
Wistedt, B., Allebeck, P., & Rodvall, Y. (1987) · Springer eBooks · doi:10.1007/978-1-4613-1799-9_35 · Cited by 1
Person-based information from Canadian hospital discharge data.
Johansen, H., Chagani, K., Lessard, S., & Nair, C. (1996) · PubMed · Cited by 1
Cited by
Sorted by citations
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,101
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 858
Epidemiology and genetics of rheumatoid arthritis.
Silman, A. J., & Pearson, J. E. (2002) · Arthritis Research · doi:10.1186/ar578 · Cited by 985
Excess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913
Physical illness and schizophrenia: a review of the literature
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633
Metadata
- Authors
- Oken, R. J., & Schulzer, M.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Oken, R. J.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-01-01
- Volume
- 25
- Issue
- 4
- Pages
- 625-638
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2100059339
- Cited by
- 129
- References
- 84
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 9 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 4 · 2016: 5 · 2015: 4 · 2014: 10 · 2013: 6 · 2012: 13
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Bulletin (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Keywords
- schizophrenia, rheumatoid arthritis
- MeSH terms
- Adult, Aged, Arthritis, Rheumatoid, Female, Humans, Male, Middle Aged, Schizophrenia, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review